Kv1.3 potassium channel blockers (Bionomics)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKv1.3 potassium channel blockers (Bionomics)
Drug Alias NameKv1.3 potassium channel blockers (Merck Serono/Bionomics)ShK toxin derivatives (Bionomics/Walter and Eliza Hall Institute)ShK toxin derivatives (Iliad/Walter and Eliza Hall Institute)khellinone-based Kv1.3 potassium channel blockers (Bionomics/Walter and Eliza Hall Institute)Kv1.3 potassium channel blockers (Iliad/Walter and Eliza Hall Institute) +[9] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectantsVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsInflammationAutoimmune DiseasesPsoriasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaIliad Chemicals Pty LtdBionomics Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesPsoriasis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A